Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)
Clinical trial NCT00038805 · TERMINATED
Trial details
- NCT number
- NCT00038805
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-05-01
- Primary completion
- 2004-11-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.